These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34281830)

  • 1. Gelsolin Governs the Neuroendocrine Transdifferentiation of Prostate Cancer Cells and Suppresses the Apoptotic Machinery.
    Oelrich F; Junker H; Stope MB; Erb HHH; Walther R; Venz S; Zimmermann U
    Anticancer Res; 2021 Aug; 41(8):3717-3729. PubMed ID: 34281830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells.
    Moritz T; Venz S; Junker H; Kreuz S; Walther R; Zimmermann U
    Tumour Biol; 2016 Aug; 37(8):10435-46. PubMed ID: 26846108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells.
    Hashimoto K; Kyoda Y; Tanaka T; Maeda T; Kobayashi K; Uchida K; Kitamura H; Hirata K; Tsukamoto T; Masumori N
    Lab Invest; 2015 Mar; 95(3):283-95. PubMed ID: 25581609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deregulation of miR-17/CCND1 axis during neuroendocrine transdifferentiation of LNCaP prostate cancer cells.
    Dankert JT; Wiesehöfer M; Czyrnik ED; Singer BB; von Ostau N; Wennemuth G
    PLoS One; 2018; 13(7):e0200472. PubMed ID: 30001402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.
    Yuan TC; Veeramani S; Lin MF
    Endocr Relat Cancer; 2007 Sep; 14(3):531-47. PubMed ID: 17914087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The β
    Braadland PR; Ramberg H; Grytli HH; Urbanucci A; Nielsen HK; Guldvik IJ; Engedal A; Ketola K; Wang W; Svindland A; Mills IG; Bjartell A; Taskén KA
    Mol Cancer Res; 2019 Nov; 17(11):2154-2168. PubMed ID: 31395667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages induce neuroendocrine differentiation of prostate cancer cells via BMP6-IL6 Loop.
    Lee GT; Kwon SJ; Lee JH; Jeon SS; Jang KT; Choi HY; Lee HM; Kim WJ; Lee DH; Kim IY
    Prostate; 2011 Oct; 71(14):1525-37. PubMed ID: 21374653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory chain enzyme deficiency induces mitochondrial location of actin-binding gelsolin to modulate the oligomerization of VDAC complexes and cell survival.
    García-Bartolomé A; Peñas A; Marín-Buera L; Lobo-Jarne T; Pérez-Pérez R; Morán M; Arenas J; Martín MA; Ugalde C
    Hum Mol Genet; 2017 Jul; 26(13):2493-2506. PubMed ID: 28431142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia Augments Increased HIF-1α and Reduced Survival Protein p-Akt in Gelsolin (GSN)-Dependent Cardiomyoblast Cell Apoptosis.
    Yeh YL; Hu WS; Ting WJ; Shen CY; Hsu HH; Chung LC; Tu CC; Chang SH; Day CH; Tsai Y; Huang CY
    Cell Biochem Biophys; 2016 Jun; 74(2):221-8. PubMed ID: 27193608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular transcriptomics: gelsolin negatively regulates the expression of apoptosis-associated genes and inhibits apoptosis in hepatocarcinoma cells.
    Zhou Y; Deng X; Ma X; Zang N; Li H; Li G; Li D; Li C; Huang W; He M
    Int J Clin Exp Pathol; 2015; 8(11):13871-85. PubMed ID: 26823700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phthalates deregulate cell proliferation, but not neuroendocrine transdifferentiation, in human LNCaP prostate cancer cell model.
    Hrubá E; Pernicová Z; Pálková L; Souček K; Vondráček J; Machala M
    Folia Biol (Praha); 2014; 60 Suppl 1():56-61. PubMed ID: 25369342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR-654-5p and miR-450b-5p.
    Zhang J; Furuta T; Sabit H; Tamai S; Jiapaer S; Dong Y; Kinoshita M; Uchida Y; Ohtsuki S; Terasaki T; Zhao S; Nakada M
    Cancer Sci; 2020 Jul; 111(7):2413-2422. PubMed ID: 32324311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST).
    Zhu Y; Liu C; Cui Y; Nadiminty N; Lou W; Gao AC
    Prostate; 2014 Aug; 74(11):1086-94. PubMed ID: 24819501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer.
    Dong B; Miao J; Wang Y; Luo W; Ji Z; Lai H; Zhang M; Cheng X; Wang J; Fang Y; Zhu HH; Chua CW; Fan L; Zhu Y; Pan J; Wang J; Xue W; Gao WQ
    Commun Biol; 2020 Dec; 3(1):778. PubMed ID: 33328604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine transdifferentiation of prostate carcinoma cells and its prognostic significance.
    Marcu M; Radu E; Sajin M
    Rom J Morphol Embryol; 2010; 51(1):7-12. PubMed ID: 20191113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXA1 inhibits prostate cancer neuroendocrine differentiation.
    Kim J; Jin H; Zhao JC; Yang YA; Li Y; Yang X; Dong X; Yu J
    Oncogene; 2017 Jul; 36(28):4072-4080. PubMed ID: 28319070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells.
    Pernicová Z; Slabáková E; Fedr R; Šimečková Š; Jaroš J; Suchánková T; Bouchal J; Kharaishvili G; Král M; Kozubík A; Souček K
    Mol Cancer; 2014 May; 13():113. PubMed ID: 24884804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine Transdifferentiation in Human Prostate Cancer Cells: An Integrated Approach.
    Cerasuolo M; Paris D; Iannotti FA; Melck D; Verde R; Mazzarella E; Motta A; Ligresti A
    Cancer Res; 2015 Aug; 75(15):2975-86. PubMed ID: 26069250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells.
    Uysal-Onganer P; Kawano Y; Caro M; Walker MM; Diez S; Darrington RS; Waxman J; Kypta RM
    Mol Cancer; 2010 Mar; 9():55. PubMed ID: 20219091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular features of treatment-related neuroendocrine prostate cancer.
    Akamatsu S; Inoue T; Ogawa O; Gleave ME
    Int J Urol; 2018 Apr; 25(4):345-351. PubMed ID: 29396873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.